Abstract
The ability of normal mice to mount an SV40 T antigen-specific cytolytic T lymphocytes response when immunized in vivo with splenocytes from the SV40 T antigen transgenic 427-line mice and restimulated in vitro with SV40-transformed fibroblasts, or when immunized with SV40 and restimulated with 427-line splenocytes, was analyzed. Both immunization schemes resulted in an SV40 T antigen-specific immune response, indicating the presence of SV40 T antigen-positive cells in the spleens of these transgenic mice. Normal mice engrafted with skin from 427 donors showed no rejection of the graft. Thus, SV40 T antigen in transgenic 427-line mice is expressed on an undefined cell type in the spleen and acts as a tissue-specific minor histocompatibility antigen.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bailey, D.: Genetics of histocompatibility in mice. I. New loci and congenic lines. Immunogenetics 2: 249–256, 1975
Bailey, D. and Usama, B.: A rapid method of grafting skin on tails of mice. Transplant Bull 7: 424–428, 1960
Brinster, R. L., Chen, H., Messing, A., Van Dyke, T., Levine, A., and Palmiter, R.: Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37: 367–379, 1984
Faas, S. J., Pan, S., Pinkert, C. A., Brinster, R. L., and Knowles, B. B.: SV40-transgenic mice that develop tumors are specifically tolerant to SV40 T-antigen. J Exp Med 165: 417–427, 1987
Gilligan, A., Jewett, L., Simon, D., Damjanov, I., Matschinski, F., Pinkert, C., and Knowles, B. B. Functional β-islet cell line from an SV40 T antigen transgenic mouse. Diabetes, in press, 1989
Gooding, I.: Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic cells. J Immunol 118: 920–927, 1977
Graff, R. J.: Minor histocompatibility genes and their antigens. In H. C. Morse III (ed.): Origins of Inbred Mice, p. 317, Academic Press, New York, 1978
Juretic, A., Nagy, Z. A., and Klein, J.: Generation of cytotoxic T lymphocytes by H-2-encoded E molecules. Immunogenetics 14:73–83, 1981
Knowles, B. B., Koncar, M., Pfizenmaier, K., Softer, D., Aden, D., and Trinchieri, G.: Genetic control of cytotoxic T cell response to SV40 tumor-associated specific antigen. J Immunol 122: 1798–1806, 1979
Marrack, P., Lo, D., Brinster, R. L., Palmiter, R., Burkly, L., Flavell, R. H., and Kappler, J.: The effect of thymus environment on T cell development and tolerance. Cell 53: 627–634, 1988
Palmiter, R. D., Howe, C. Y., Messing, A., and Brinster, R. L.: SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumors in transgenic mice. Nature 316: 457–460, 1985
Scheid, M., Boyse, E., Carswell, E., and Old, L.: Serological demonstrable alloantigens of mouse epidermal cells. J Exp Med 135: 938–955, 1972
Wettstein, P. J. and Colombo, M. P.: Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens. J Immunol 139: 2166–2171, 1987
Wettstein, P. J., Jewett, L., Faas, S., Brinster, R. L., and Knowles, B. B.: SV40 T-antigen is a histocompatibility antigen of SV40transgenic mice. Immunogenetics 27: 436–441, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Juretic, A., Knowles, B.B. SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice. Immunogenetics 29, 366–370 (1989). https://doi.org/10.1007/BF00375864
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00375864